RECRUITING

Understanding Patient Preference on Colorectal Cancer Screening Options-PSU

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

There are significant barriers to colorectal cancer screening within underserved populations due to the cost, accessibility, and acceptability of screening methods. Patient-friendly approaches that minimize stress and discomfort for the patient are needed to enhance screening compliance and achieve an early diagnosis. The primary aim of this study is to examine whether the availability of a blood-based screening option, which can be done at the point of service and is familiar to patients, will improve patient compliance to recommended CRC screening

Official Title

Understanding Patient Preference on Colorectal Cancer Screening Options

Quick Facts

Study Start:2024-09-16
Study Completion:2026-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06444542

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:45 Years to 75 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Not specified
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Between 45-75 years of age
  2. 2. Language Proficiency: participants must be fluent in English or Spanish
  3. 3. Have an average risk for colorectal cancer
  4. 4. Be a patient at one of our partner FQHCs
  5. 5. Received a screening order (either using a stool-based test or colonoscopy) six months ago and failed or refused to complete the screening test
  6. 6. Able and willing to provide a blood sample per protocol
  1. 1. Family history
  2. * One first-degree relative diagnosed with CRC or advanced adenoma at age \<60 years
  3. * Two first-degree relatives diagnosed with CRC or advanced adenoma at any age
  4. * Known hereditary gastrointestinal cancer syndromes, such as Lynch Syndrome or Familial Adenomatous and Polyposis (FAP)
  5. 2. Personal History
  6. * Participants who do not speak either Spanish or English
  7. * History of CRC or adenoma
  8. * History of cancers
  9. * History of inflammatory bowel disease, including chronic ulcerative colitis and Crohn's disease
  10. * Have a recorded up to date CRC screening
  11. * Blood product transfusion in the past 120 days
  12. * A medical condition which, in the opinion of the patient's health provider, should preclude enrollment in the study

Contacts and Locations

Study Contact

Paula Lozano, PhD
CONTACT
312-535-3750
plozanomesa@pennstatehealth.psu.edu

Principal Investigator

Karen E. Kim, MD
PRINCIPAL_INVESTIGATOR
Penn State College of Medicine

Study Locations (Sites)

Penn State College of Medicine
Hershey, Pennsylvania, 17033
United States

Collaborators and Investigators

Sponsor: Milton S. Hershey Medical Center

  • Karen E. Kim, MD, PRINCIPAL_INVESTIGATOR, Penn State College of Medicine

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-09-16
Study Completion Date2026-12-31

Study Record Updates

Study Start Date2024-09-16
Study Completion Date2026-12-31

Terms related to this study

Additional Relevant MeSH Terms

  • Colo-rectal Cancer